In summary, we successfully generated an ApoA5-deficient hamster model targeted by CRISPR/cas9 gene editing, which showed severe HTG with low-grade inflammation, leading to hepatic steatosis under chow diet condition. This evidence concerns the gene APOA5 and fatty liver disease.